The presence of high density of CD3+CD8+CD45RO+ immune cells within tumor region is correlated with favorable clinical outcome in epithelial ovarian cancer [13], while the number of effector CD8+ T cells in TILs decreased in lung cancer [14]. Here, CD8A is linked to lung cancer.